Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy.
Guihua Zhang, Weiqi Chen, Haoyu Chen...
https://pubmed.ncbi.nlm.nih.gov/38750958/Actively Recruiting
Led by Qilu Hospital of Shandong University · Updated on 2026-07-28
98
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are studying how blood flows through the iris in adults aged 18 years and older, including healthy people and those with type 2 diabetes and related eye problems such as diabetic retinopathy and neovascular glaucoma. This observational study aims to compare iris blood flow in different groups to understand how blood circulation changes with worsening diabetic eye disease and whether these measures can help identify neovascular glaucoma. Participants will undergo a painless, non-invasive iris optical coherence tomography angiography OCTA scan to capture images of blood flow in six areas around the pupil. The study includes four groups healthy controls, type 2 diabetes without diabetic retinopathy, type 2 diabetic retinopathy, and type 2 diabetic retinopathy with neovascular glaucoma. Researchers will analyze differences in iris blood flow among these groups and explore gender and quadrant-specific variations. During the study, participants will provide basic personal information, medical history, and recent routine lab results. They will receive iris OCTA scans to measure iris vessel density. The main outcome measured is the density of iris blood vessels. No invasive procedures are involved, and participants cooperation in stabilizing their head during scanning is important. The study will continue until the end of 2026.
CONDITIONS
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
Y
Yuting Zhang, Doctor of Medicine
H
Hui Guo, Doctor of Medicine
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Qilu Hospital of Shandong University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - One-time visit
Participants provide medical history and routine lab results, then receive a painless iris OCTA eye scan to measure blood flow in six areas around the pupil.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Guihua Zhang, Weiqi Chen, Haoyu Chen...
https://pubmed.ncbi.nlm.nih.gov/38750958/Alcina K Lidder, Vikram Paranjpe, Alison J Lauter
https://pubmed.ncbi.nlm.nih.gov/37755450/Rania Elsaied Elkholy, Amira Mohamed El Sharkawy, Hala Ibrahim Hantash...
https://pubmed.ncbi.nlm.nih.gov/42435066/Zhihao Qi, Yuanyuan Si, Feng Feng...
https://pubmed.ncbi.nlm.nih.gov/37293481/Teresa Barth, Horst Helbig
https://pubmed.ncbi.nlm.nih.gov/34380155/Dimitrios Kalogeropoulos, George Moussa, Velota Ct Sung...
https://pubmed.ncbi.nlm.nih.gov/36436509/Qilu Hospital of Shandong University
Lead Sponsor